ARCHIVES

Pediatric Rule Makes FDA Consider Defining Tumors By Molecular Target.

This article is from The Cancer Letter archive.

Vol. 27 No. 31 | August 31, 2001

Download PDF Visit The Full Archive

Related Articles

Risk-Benefit Analysis Advised Prior To Hormone Therapy

August 27, 2010

ASCO Objects To Proposed Graduate Medical Education Bill

September 20, 1985

In Congress: House Subcommittee Postpones FY2000 Markup; Porter Seeks 8% increase for NIH

July 23, 1999

National TV Attack On Cancer Program Gets Response From Schmidt; Some NCAB Members Side With Kornberg

June 28, 1974

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

October 3, 2014

New Jersey Legislature Votes to Oppose USPSTF PSA Screening Downgrade

January 20, 2012